Femme et Homme
- | Pays :
- India
- | Organes : -
- | Spécialités : -
Extrait
This study is to evaluate the antiviral efficacy of add-on adefovir to telbivudine in non-responders to telbivudine monotherapy after 24 and 36 initial weeks. Antiviral efficacy is assessed by hepatitis B virus (HBV) DNA non-detectability (PCR <300 copies/ml) by week 104 with CHB.
Critère d'inclusion
- Hepatitis B, Chronic